A restrictor complex of ZC3H4, WDR82, and ARS2 integrates with PNUTS to control unproductive transcription.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
06 Jul 2023
Historique:
received: 02 09 2022
revised: 29 03 2023
accepted: 18 05 2023
medline: 10 7 2023
pubmed: 18 6 2023
entrez: 17 6 2023
Statut: ppublish

Résumé

The transcriptional termination of unstable non-coding RNAs (ncRNAs) is poorly understood compared to coding transcripts. We recently identified ZC3H4-WDR82 ("restrictor") as restricting human ncRNA transcription, but how it does this is unknown. Here, we show that ZC3H4 additionally associates with ARS2 and the nuclear exosome targeting complex. The domains of ZC3H4 that contact ARS2 and WDR82 are required for ncRNA restriction, suggesting their presence in a functional complex. Consistently, ZC3H4, WDR82, and ARS2 co-transcriptionally control an overlapping population of ncRNAs. ZC3H4 is proximal to the negative elongation factor, PNUTS, which we show enables restrictor function and is required to terminate the transcription of all major RNA polymerase II transcript classes. In contrast to short ncRNAs, longer protein-coding transcription is supported by U1 snRNA, which shields transcripts from restrictor and PNUTS at hundreds of genes. These data provide important insights into the mechanism and control of transcription by restrictor and PNUTS.

Identifiants

pubmed: 37329883
pii: S1097-2765(23)00385-4
doi: 10.1016/j.molcel.2023.05.029
pii:
doi:

Substances chimiques

RNA Polymerase II EC 2.7.7.-
RNA, Untranslated 0
WDR82 protein, human 0
Chromosomal Proteins, Non-Histone 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2222-2239.e5

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Chris Estell (C)

Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom.

Lee Davidson (L)

Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom.

Joshua D Eaton (JD)

Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom.

Hiroshi Kimura (H)

Cell Biology Centre, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan.

Vicki A M Gold (VAM)

Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom.

Steven West (S)

Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom. Electronic address: s.west@exeter.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH